Biocartis
Several new studies appear to confirm the test's potential to prevent overtreatment of melanoma patients while identifying those at high risk.
Biocartis, Merck KGaA Extend RAS Testing Partnership to Middle East, North Africa
The companies hope to improve access to biomarker testing to direct more personalized treatment for cancer patients in the region.
In Brief This Week: Prenetics, Biocartis, LabCorp, Legacy Health, Proteomics International, Sapphiros
News items for the week of Nov. 20, 2023
In Brief This Week: Myriad Genetics, Labcorp, MDxHealth, Biocartis, Epigenomics, Theradiag, More
News items for the week of Oct. 9, 2023.
Biocartis Restructures Balance Sheet as H1 2023 Revenues Rise 12 Percent
The company said that its secured creditors have recapitalized its operating subsidiaries and restructured its balance sheet to reduce its debt burden by €132 million.
Oct 10, 2022
Ophiomics Liver Cancer Assay Gets CE-IVD Mark
Sep 1, 2022
Biocartis Posts 21 Percent Jump in H1 Revenues
Jun 22, 2022
Biocartis, AstraZeneca Ink Companion Diagnostic Pact
Jun 20, 2022
Biocartis Nabs CE Mark for Lung Cancer Test
Feb 24, 2022